Questions? Call us at (888) 344-8463

1x
HOW IT WORKS FAQs SERVICES
☰

Forever Labs Blog

The latest news and research from Forever Labs

Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.

posted by: Mark Katakowski

As human lifespan increases, a greater fraction of the population is suffering from age-related cognitive impairments, making it important to elucidate a means to combat the effects of aging. Here ...

Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial.

posted by: Mark Katakowski

OBJECTIVE To assess in multiple sclerosis (MS) the effect of intense immunosuppression followed by autologous hematopoietic stem cells transplantation (AHSCT) vs mitoxantrone (MTX) on disease activ...

Cells derived from young bone marrow alleviate renal aging.

posted by: Mark Katakowski

Bone marrow-derived stem cells may modulate renal injury, but the effects may depend on the age of the stem cells. Here we investigated whether bone marrow from young mice attenuates renal aging in...

Effect on lifespan of high yield non-myeloablating transplantation of bone marrow from young to old mice.

posted by: Mark Katakowski

Tissue renewal is a well-known phenomenon by which old and dying-off cells of various tissues of the body are replaced by progeny of local or circulating stem cells (SCs). An interesting question i...

Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells.

posted by: Mark Katakowski

Human bone marrow-derived mesenchymal cells contain mesenchymal stem cells (MSCs), which are well known for their osteo/chondrogenic potential and can be used for bone reconstruction. This article ...

Long-term cryopreservation of bone marrow for autologous transplantation.

posted by: Mark Katakowski

Little is known about the effect of long-term cryopreservation on the viability of hematopoietic stem cells (HSC) or on the success of autologous bone marrow transplantation. Although progenitor ce...

Transplantation of mesenchymal stem cells from young donors delays aging in mice.

posted by: Mark Katakowski

Increasing evidence suggests that the loss of functional stem cells may be important in the aging process. Our experiments were originally aimed at testing the idea that, in the specific case of a...

Stem cell transplantation improves aging-related diseases.

posted by: Mark Katakowski

Aging is a complex process of damage accumulation, and has been viewed as experimentally and medically intractable. The number of patients with age-associated diseases such as type 2 diabetes mell...

Donor's age dependent proliferation decrease of human bone marrow mesenchymal stem cells is linked to diminished clonogenicity.

posted by: Mark Katakowski

While mesenchymal stem cells represent an interesting cell source for regenerative medicine, several points have to be investigated to improve their use in clinical, and in particular in the elder...

Stem Cell Research Updates

Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.

posted by: Mark Katakowski

As human lifespan increases, a greater fraction of the population is suffering from age-related cognitive impairments, making it important to elucidate a means to combat the effects of aging. Here ...

Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial.

posted by: Mark Katakowski

OBJECTIVE To assess in multiple sclerosis (MS) the effect of intense immunosuppression followed by autologous hematopoietic stem cells transplantation (AHSCT) vs mitoxantrone (MTX) on disease activ...

Cells derived from young bone marrow alleviate renal aging.

posted by: Mark Katakowski

Bone marrow-derived stem cells may modulate renal injury, but the effects may depend on the age of the stem cells. Here we investigated whether bone marrow from young mice attenuates renal aging in...

Effect on lifespan of high yield non-myeloablating transplantation of bone marrow from young to old mice.

posted by: Mark Katakowski

Tissue renewal is a well-known phenomenon by which old and dying-off cells of various tissues of the body are replaced by progeny of local or circulating stem cells (SCs). An interesting question i...

Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells.

posted by: Mark Katakowski

Human bone marrow-derived mesenchymal cells contain mesenchymal stem cells (MSCs), which are well known for their osteo/chondrogenic potential and can be used for bone reconstruction. This article ...

Long-term cryopreservation of bone marrow for autologous transplantation.

posted by: Mark Katakowski

Little is known about the effect of long-term cryopreservation on the viability of hematopoietic stem cells (HSC) or on the success of autologous bone marrow transplantation. Although progenitor ce...

Transplantation of mesenchymal stem cells from young donors delays aging in mice.

posted by: Mark Katakowski

Increasing evidence suggests that the loss of functional stem cells may be important in the aging process. Our experiments were originally aimed at testing the idea that, in the specific case of a...

Stem cell transplantation improves aging-related diseases.

posted by: Mark Katakowski

Aging is a complex process of damage accumulation, and has been viewed as experimentally and medically intractable. The number of patients with age-associated diseases such as type 2 diabetes mell...

Donor's age dependent proliferation decrease of human bone marrow mesenchymal stem cells is linked to diminished clonogenicity.

posted by: Mark Katakowski

While mesenchymal stem cells represent an interesting cell source for regenerative medicine, several points have to be investigated to improve their use in clinical, and in particular in the elder...